Third-Party Reviews Should Be Used Only If Expertise Is Lacking – MDMA
This article was originally published in The Gray Sheet
Executive Summary
The Medical Device Manufacturers Association is seeking to toughen FDA device reform legislation to prevent outside expert reviews of PMAs from occurring unless the agency lacks resources to conduct the reviews in-house